SPY396.92+7.29 1.87%
DIA318.84+6.42 2.05%
IXIC11,535.28+180.66 1.59%

Rezolute Says Study in Congenital Hyperinsulinism Achieves 75% Reduction in Hypoglycemia Events; Prices $130 Million Offering

MT Newswires · 05/01/2022 23:58

Please log in to view news